U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07174882) titled 'Evaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa Resistance' on Dec. 02, 2024.
Brief Summary: GERD is characterized by a high prevalence (about 13.3%) and is associated with a deterioration in the quality of life, as well as an increased risk of esophageal adenocarcinoma and a rise in the number of refractory cases. NERD is one of the forms of GERD, accounting for about 70% of all cases, and is characterized by symptoms that reduce the quality of life. Although proton pump inhibitors (PPIs) are the basic therapy for NERD, up to 40% of patients do not achieve an optimal clinical outcome. GERD symptom...